Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Agreed but even if the respondents don't get a timely response (before the '808 actually expires), it appears that a favorable ruling after remand back to the court of appeals (should that occur) regardless of timing bodes well for the actual risk of (not) ever having to pay damages later on making an at risk launch a much lower risk proposition. The amicus brief seemed to indicate the likelihood the indefinite ness of the '808 would probably stand. Thanks to mouton and Dew for bird dodging this. bp